|
TTC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.087000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.689400E-01 |
| Normal-vs-Stage2 |
7.497800E-01 |
| Normal-vs-Stage3 |
5.400600E-01 |
| Normal-vs-Stage4 |
6.992200E-01 |
| Stage1-vs-Stage2 |
7.149400E-01 |
| Stage1-vs-Stage3 |
4.532000E-01 |
| Stage1-vs-Stage4 |
6.687200E-01 |
| Stage2-vs-Stage3 |
8.914000E-01 |
| Stage2-vs-Stage4 |
9.834400E-01 |
| Stage3-vs-Stage4 |
8.400200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.723800E-01 |
| Normal-vs-AfricanAmerican |
2.567600E-01 |
| Normal-vs-Asian |
8.748200E-01 |
| Caucasian-vs-AfricanAmerican |
1.820010E-01 |
| Caucasian-vs-Asian |
8.462400E-01 |
| AfricanAmerican-vs-Asian |
1.839830E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.181200E-01 |
| Normal-vs-Female |
9.224400E-01 |
| Male-vs-Female |
1.191630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.706400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.186200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.938400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.331800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.658200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.108200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.066600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.799800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.356400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.366600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.833200E-01 |
| Classical-VS-Follicular |
3.70540000016462E-07 |
| Classical-VS-Other |
8.137900E-02 |
| Classical-VS-Normal |
3.084800E-01 |
| Tall-VS-Follicular |
2.760100E-02 |
| Tall-VS-Other |
1.821400E-01 |
| Tall-VS-Normal |
9.521200E-01 |
| Follicular-VS-Other |
9.354400E-01 |
| Follicular-VS-Normal |
6.222900E-03 |
| Other-VS-Normal |
1.398570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.919800E-01 |
| Normal-vs-N1 |
2.384400E-01 |
| N0-vs-N1 |
5.586200E-01 |
|
|
